Please assess the completion status of the following clinical trial:

Trial Title: Progesterone for Prevention of Preterm Birth in Women With Short Cervix: Randomized Controlled Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* All women with singleton or twin pregnancies attending for routine ultrasound examination at 20-25 weeks of gestation with a short cervical length (\<15 mm).~Exclusion Criteria:~* Women with major fetal abnormalities,~* Painful regular uterine contractions, or history of ruptured membranes or cervical cerclage in-situ were excluded from screening.

- Gender: FEMALE
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).